Topic: Infections
Evolutions and Revolutions in HS
Series: Maui Derm for Dermatologists 2020 | January 27, 2020
The past decade has seen significant advances in the understanding of hidradenitis suppurativa pathogenesis, informing research into novel treatment approaches, such as biologics, and expanded indications for existing pharmacologic agents. Ali Alikhan, MD reviews the evolving landscape in HS and revolutions in treatment approaches.
Ask an Expert: How Do You Treat Hidradenitis Suppurativa?
Series: Ask an Expert | November 26, 2019
In the second video in a series, Steven Cohen, MD talks about standard and new treatments for hidradenitis suppurativa. He talks to host Adam Friedman, MD about optimized regimens and long-term patient support.
Ask an Expert: What's the Role for Infliximab in HS?
Series: Ask an Expert | September 27, 2019
Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.
Ask an Expert: What Do We Know about QoL in Hidradenitis Suppurativa
Series: Ask an Expert | September 27, 2019
With a surge in new research over the last decade, dermatologists are learning more about Hidradenitis Suppurativa, comorbidities, and quality of life impact. In the first of a series, Steven Cohen, MD discusses HS with host Adam Friedman, MD.
